1)Melmed S:Medical progress;Acromegaly. N Engl J Med 355:2558-2573, 2006
2)Melmed S:Acromegaly pathogenesis and treatment. J Clin Invest 119:3189-3202, 2009
3)Melmed S, et al:Guidelines for acromegaly management;An update. J Clin Endocrinol Metab 94:1509-1517, 2009
4)Ho KK, 2007 GH Deficiency Consensus Workshop Participants:Consensus guidelines for the diagnosis and treatment of adults with GH deficiency Ⅱ;A statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. Eur J Endocrinol 157:695-700, 2007
5)Molitch ME, et al:Evaluation and treatment of adult growth hormone deficiency;An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1587-1609, 2011
6)厚生労働科学研究費補助金 難治性疾患等政策研究事業「間脳下垂体機能障害に関する調査研究」班,日本内分泌学会(編):間脳下垂体機能障害の診断と治療の手引き(平成30年度改訂).日内分泌会誌95(Suppl):1-60, 2019
7)Lissett CA, et al:Determinants of IGF-I status in a large cohort of growth hormone-deficient(GHD)subjects;The role of timing of onset of GHD. Clin Endocrinol(Oxf)59:777-778, 2003
8)Isojima T, et al:Standardized centile curves and reference intervals of serum insulin-like growth factor-Ⅰ(IGF-Ⅰ)levels in a normal Japanese population using the LMS method. Endocr J 59:771-780, 2012
9)Katznelson L, et al:Acromegaly;An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 99:3933-3951, 2014
10)Sherlock M, et al:Medical therapy in acromegaly. Nat Rev Endocrinol 7:291-300, 2011
11)Melmed S, et al:A consensus statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14:552-561, 2018
12)Tauber M, et al:Growth hormone(GH)retesting auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 82:352-356, 1997